about
Emerging molecular classifications and therapeutic implications for gastric cancerEpstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developmentsEpstein-Barr virus and the origin of Hodgkin lymphomaEpstein-Barr Virus: Diseases Linked to Infection and TransformationCo-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesisOccipital lymph node metastasis from nasopharyngeal carcinoma: a special case report and literature reviewEpstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesisSerum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer.A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinomaHigh expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapyCOX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization systemCytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis.A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinomaCarcinogenesis of nasopharyngeal carcinoma: an alternate hypothetical mechanism.The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma.Epstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma.The presence of human papillomavirus and Epstein-Barr virus in male Chinese lichen sclerosus patients: a single center study.Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver.Subtype distribution and long-term titer fluctuation patterns of serum anti-Epstein-Barr virus antibodies in a non-nasopharyngeal carcinoma population from an endemic area in South China: a cohort study.Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area.Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma.Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma.Epstein-Barr virus infection and nasopharyngeal carcinoma.Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.Causal role of infectious agents in cancer: An overview.Nasopharyngeal carcinoma presenting as an inconspicuous primary lesion with extensive cavernous sinus involvement and temporal lobe extension: a case report and review of literatureEpstein-Barr virus at 50-future perspectives.Viral Oncology: Molecular Biology and Pathogenesis.Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment.Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study.The Role of Epstein-Barr Virus in Cervical Cancer: A Brief Update.Long non-coding RNA ZNF674-1 acts as a cancer suppressor in nasopharyngeal carcinoma.An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse modelActivation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma
P2860
Q26745525-A63C655E-B2AA-4B5A-8937-6E8439EDE855Q26775442-5F83E903-2614-40E5-B26D-0E56453C9825Q26998999-218815D1-6546-4D38-B655-762D2AA6CB10Q28074586-CE0305FA-646F-42D9-8B61-530E3A7E8514Q28077209-FCE54A9E-4274-46E7-B60F-5053E8A9F8EFQ28078860-018A6992-0AE4-45E2-91AC-D3E79B8BFC50Q28079510-418C57D7-F433-4CA6-B768-7C3B5C01FE4AQ33743639-071ECF00-E4E4-4516-918D-14897B8B1E1AQ33890586-D4917E7E-A70E-46AF-A68C-0A0C80635FAAQ35686424-A82868A3-AD45-4A51-AD65-6A14161799C6Q36110362-9639EC34-3487-4818-9E3B-BC4ECDAEF295Q36121121-DCAC6748-E091-4A48-A7AD-617AA885A7BBQ36121349-1DFF9CB5-5207-4C11-B288-1F4169CA6735Q36424931-C4AC736E-EFD2-4BC6-AF76-E44C4F61F4A8Q36439304-DCA81D4F-B7DF-448C-9703-DA738F5D9D07Q36562258-DBA34824-0C58-4C6C-8364-CD0C9E335E65Q37022378-2028C83C-DEEC-4D93-93B4-2AB4F3E3B2F2Q37086039-F7291310-429D-49D8-B5A1-6B9719ED2959Q37113211-EB8D337B-A121-43CA-A6B1-6042550A327AQ37139928-A0FAB021-8873-42C0-BF91-DF6D2C2D121AQ37178265-A6B45B88-EA6B-4DD4-ADCB-E2BF2C3A3B93Q37301919-01D1B4EE-2E47-443D-BCD4-FF3E923F69BFQ37442510-EAAB49C2-EAA9-4462-8D13-7CF12D99A981Q37465628-274EF075-D2E1-4442-A984-F56E558E967FQ37536465-0BEE4C29-0043-49B3-B2F9-4AAB1C64E615Q37736423-9B43AF45-EE3A-488D-9958-434C6ED832B2Q38701014-48CEA92A-EE09-4AD8-BC22-AFDCEA7C6082Q40046633-886C9D2A-63FA-4797-8D85-509A82C59B73Q40339509-A3DBA5A6-8E5C-4473-AA5A-DBB3CDC2BD82Q41187516-437674D4-298E-4470-943C-4024CC3F62A5Q42279542-995B94EC-CC51-4D9E-9442-79FBCDC30181Q43035017-1A41F780-0452-4DC0-9F3A-92A74D39FE81Q47571734-318362DD-435B-45FD-BC16-083E77732DE7Q49787173-541BCAE8-1647-4801-8D66-73DD1E36BEE0Q54594897-E58AC27F-9516-4D9D-BEFE-C6A4BFAA7840Q55119105-BA7414BF-9AD5-4D08-8C94-0E2CEFBDA209Q55264382-930F0349-997B-4C66-9CA5-3D0842FA0796Q55279099-A5AB1F8D-19C9-4CA8-A707-4BD72C992616Q57025486-9C77A379-847E-468C-B924-93E5E25D2E7BQ57782075-AC89F3C4-EF25-4E53-8952-0D28516C386D
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2014
@uk
name
Epstein-Barr virus and nasopharyngeal carcinoma
@en
Epstein-Barr virus and nasopharyngeal carcinoma
@nl
type
label
Epstein-Barr virus and nasopharyngeal carcinoma
@en
Epstein-Barr virus and nasopharyngeal carcinoma
@nl
prefLabel
Epstein-Barr virus and nasopharyngeal carcinoma
@en
Epstein-Barr virus and nasopharyngeal carcinoma
@nl
P2860
P356
P1476
Epstein-Barr virus and nasopharyngeal carcinoma
@en
P2093
Christopher W Dawson
P2860
P304
P356
10.5732/CJC.014.10197
P407
P577
2014-12-01T00:00:00Z